A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

NCT02772081 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Respiratory Distress Syndrome (RDS)

Interventions

COMBINATION_PRODUCT: LISA combination product (Curosurf+catheter CHF6440)
DRUG: Curosurf through conventional administration (endotracheal tube)

Sponsor

Chiesi Farmaceutici S.p.A.